1 study found for:    NCT01434316
Show Display Options
Rank Status Study
1 Recruiting Veliparib and Dinaciclib With or Without Carboplatin in Treating Patients With Advanced Solid Tumors
Conditions: BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: veliparib;   Drug: dinaciclib;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study

Indicates status has not been verified in more than two years